Wuhan Renfukang Pharmaceutical Co., Ltd. was established in 2016 and is a holding subsidiary of Renfu Group. It is a comprehensive pharmaceutical company that focuses on the research and development, product declaration and commissioned production of tablets, hard capsules, freeze-dried powder injections and injections. It adheres to the innovative concept and aims to "make the tree of life evergreen". Committed to drug innovation, strive to open up the international market, and strive to build the company into an international pharmaceutical service company.

　　'S main business: CDMO services for tablets, hard capsules, freeze-dried powder injections and injections.